ArticlePloS one2021

Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study.

Yi-Cheng Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.